HealthcareServices

Global Viral Gastroenteritis Market Report 2026–2030: Data-Driven Growth Insights

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the viral gastroenteritis market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Viral Gastroenteritis Market be in 2030 compared with 2026?

The viral gastroenteritis market has demonstrated significant growth in recent years. It is anticipated to increase from $7.06 billion in 2025 to $7.43 billion in 2026, at a compound annual growth rate (CAGR) of 5.1%. This historical expansion can be credited to factors such as elevated public health awareness, wider availability of healthcare services, the existence of fundamental diagnostic tools, the growing application of oral rehydration solutions, and enhanced disease reporting mechanisms.

The viral gastroenteritis market is projected to experience substantial growth in the coming years, reaching $9.2 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. This expansion during the forecast period is attributed to several factors, including increasing investments in infectious disease surveillance, a rising demand for rapid point-of-care diagnostics, the expansion of vaccination and prevention programs, a growing focus on pediatric healthcare, and the increasing adoption of digital disease monitoring. Key trends anticipated during this period encompass a heightened focus on rapid diagnostic testing, a rising demand for supportive care therapies, a growing emphasis on infection control and prevention, the expanded use of oral rehydration and zinc therapy, and enhanced surveillance of viral outbreaks.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

What Drivers Are Guiding Growth Patterns In The Viral Gastroenteritis Market?

The rising occurrence of gastrointestinal disorders is projected to boost the expansion of the viral gastroenteritis market moving forward. Gastrointestinal (GI) disorders are defined as conditions affecting any part within or on the digestive tract. Viral gastroenteritis drugs and diagnostic methods provide appropriate and effective treatment for individuals suffering from this illness. For example, in September 2023, data from the Impact of IBD Report 2023, published by the Canada-based IBD Clinical and Research Centre, an organization dedicated to improving the lives of patients with Crohn’s disease and ulcerative colitis, revealed that over 320,000 people in Canada had inflammatory bowel disease (IBD) in 2023, reflecting a prevalence of 825 per 100,000. With the prevalence anticipated to increase by 2.44% annually, it is projected that 1.1% of the population, or 470,000 Canadians, will be living with IBD by 2035. Consequently, the growing prevalence of gastrointestinal disorders is driving the growth of the viral gastroenteritis market.

How Is The Viral Gastroenteritis Market Divided Into Segments?

The viral gastroenteritis market covered in this report is segmented –

1) By Drugs: Antibiotics, Antacids, Antimotility Agents, Others Drugs

2) By Diagnosis: Physical Examination, Rapid Stool Test

3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

Subsegments:

1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins

2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate

3) By Antimotility Agents: Loperamide, Diphenoxylate

4) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

Which Trends Are Influencing The Development Of The Viral Gastroenteritis Market?

Leading companies in the viral gastroenteritis market are innovating with new offerings such as PCR kits for gastrointestinal infectious diseases to enhance their competitive standing. Polymerase Chain Reaction (PCR) kits serve as molecular biology instruments for amplifying and identifying specific DNA sequences. For example, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a molecular diagnostic solutions company based in China, unveiled 10 Real-Time PCR Kits. These kits are designed for accurate detection of gastrointestinal pathogens and, when integrated with their extraction solution and PCR system, form a comprehensive Total PCR Solution. The Real-Time PCR Kits are capable of identifying various bacterial, viral, and parasitic pathogens linked to gastrointestinal infections. This includes diseases stemming from bacterial agents like Campylobacter, Salmonella, Shigella, and Clostridioides difficile, as well as viral agents such as Adenovirus, Rotavirus, Astrovirus, and Norovirus. This novel solution streamlines the entire process, from sample pre-processing to PCR amplification analysis.

Which Key Players Are Driving Competition In The Viral Gastroenteritis Market?

Major companies operating in the viral gastroenteritis market are Pfizer Inc., Sanofi S A, Abbott Laboratories, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Mylan N V, Dr Reddys Laboratories Ltd, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, ANI Pharmaceuticals Inc, Merck Sharp & Dohme Corp, Abbvie Inc, AstraZeneca Plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Roche Holding AG, BristolMyersSquibb Company, Amgen Inc, Eli Lilly and Company, Novartis AG, Johnson and Johnson, Moderna Inc, Bharat Biotech International Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

How Does The Viral Gastroenteritis Market Perform Across Major Global Regions?

North America was the largest region in the viral gastroenteritis market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Viral Gastroenteritis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12127&type=smp

Browse Through More Reports Similar to the Global Viral Gastroenteritis Market 2026, By The Business Research Company

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Viral Hepatitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Gastrointestinal Pathogen Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795